New Drug Applications Archive

New Drug Applications: October 2009

October 2 Sciele Pharma and Addrenex Announce Submission of sNDA to FDA for Clonicel to Treat ADHD
October 2 Discovery Labs and FDA Establish Path for Potential Surfaxin Approval
October 2 Merck Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United States
October 5 GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for Votrient
October 6 Orexo confirms FDA acceptance of Abstral filing
October 12 Fibrocell Science, Inc. Reports Outcome of FDA Advisory Committee Meeting on Azfibrocel-T for Wrinkles
October 14 Acorda Therapeutics Announces Positive Vote by FDA Advisory Committee for Fampridine-SR
October 21 FDA Issues Complete Response Letter for CorVue
October 21 Amgen Provides Update on Status of Prolia (denosumab) Biologics License Application (BLA) Submitted to the U.S. Food and Drug Administration (FDA)
October 22 Acorda Therapeutics Announces Extension of Fampridine-SR PDUFA Goal Date to January 22, 2010
October 22 Endo Pharmaceuticals Gives Update on Regulatory Status of Fortesta
October 23 Novartis receives Complete Response letter from FDA for QAB149, an investigational bronchodilator for COPD
October 26 Gilead's Aztreonam for Inhalation Solution to be Reviewed by FDA Anti-Infective Drugs Advisory Committee on December 10, 2009
October 30 Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo New Drug Application

New Drug Applications Archive

2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec

MedNotes
Advertisement

(web1)